NDC 52427-435

Zestoretic

Lisinopril And Hydrochlorothiazide

Zestoretic is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Almatica Pharma Inc.. The primary component is Hydrochlorothiazide; Lisinopril.

Product ID52427-435_1f1f8f5b-991d-49c0-5680-219424e3e019
NDC52427-435
Product TypeHuman Prescription Drug
Proprietary NameZestoretic
Generic NameLisinopril And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-04-15
Marketing CategoryNDA / NDA
Application NumberNDA019888
Labeler NameAlmatica Pharma Inc.
Substance NameHYDROCHLOROTHIAZIDE; LISINOPRIL
Active Ingredient Strength13 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 52427-435-90

90 TABLET in 1 BOTTLE (52427-435-90)
Marketing Start Date2015-04-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52427-435-90 [52427043590]

Zestoretic TABLET
Marketing CategoryNDA
Application NumberNDA019888
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-04-15

Drug Details

Active Ingredients

IngredientStrength
LISINOPRIL10 mg/1

OpenFDA Data

SPL SET ID:0d3a966f-f937-05a8-a90f-5aa52ebbd613
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197885
  • 823971
  • 197887
  • 197886
  • 823986
  • 823982
    • UPC Code
  • 0352427437908
  • 0352427436901
  • 0352427435904

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Zestoretic" or generic name "Lisinopril And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    52427-435ZestoreticZestoretic
    52427-436ZestoreticZestoretic
    52427-437ZestoreticZestoretic
    0185-0152Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-0173Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-7100Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0378-1012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2025Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0591-0860Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0861Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0862Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7577Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7581Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7582Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-236Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-237Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-564LISINOPRIL AND HYDROCHLOROTHIAZIDELISINOPRIL AND HYDROCHLOROTHIAZIDE
    16571-791Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    16571-792Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1262Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1263Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1264Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide

    Trademark Results [Zestoretic]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZESTORETIC
    ZESTORETIC
    73713660 1521488 Live/Registered
    IMPERIAL CHEMICAL INDUSTRIES PLC
    1988-02-26
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.